hold on there's just too much going on in Congress lmao...
Requires reports on Medicare drug plan agreements with PBMs.
Sen. Warner (D-VA) and others.
Introduced in Senate, in committee.
This bill directs the Medicare Payment Advisory Commission (MedPAC) to create two reports for Congress. These reports will look into how pharmacy benefit managers (PBMs) make agreements for Medicare prescription drug plans and Medicare Advantage plans. Senator Mark Warner (D-VA) introduced it, alongside Senators Tillis (R-NC), Cortez Masto (D-NV), and Marshall (R-KS). It is currently awaiting review by the Senate Finance Committee.
Introduced Jan 29, 2026
This bill was introduced in the Senate and sent to the Committee on Finance for review. For it to become law, it must pass both the Senate and the House of Representatives, and then be signed by the President. It has not yet had a vote in either chamber.
If this bill passes, MedPAC will eventually publish reports detailing PBM agreements with Medicare drug plans. These reports could shed light on how PBMs influence what you pay out-of-pocket for prescriptions and how pharmacies are reimbursed. This increased transparency might lead to future legislative or regulatory actions that could impact your drug costs.
Supporters Say
Supporters believe this will bring transparency to PBM practices affecting Medicare beneficiaries and pharmacies.
Critics Say
There is no explicit opposition to this bill in the provided text, as it focuses on data collection and reporting.
This bill aims to improve understanding of how pharmacy benefit managers operate within Medicare drug plans. Proponents argue that by requiring detailed reports from MedPAC, Congress and the public will gain crucial insights into PBM agreements, potentially leading to more informed policy decisions regarding drug pricing and patient costs. There is no explicit opposition stated within the bill text, as the bill focuses solely on data collection and reporting.